Cite
Yang C, Zhang Z, Tang X, et al. Pan-cancer analysis reveals homologous recombination deficiency score as a predictive marker for immunotherapy responders. Hum Cell. 2021;35(1):199-213doi: 10.1007/s13577-021-00630-z.
Yang, C., Zhang, Z., Tang, X., Zhang, X., Chen, Y., Hu, T., Zhang, H., Guan, M., Zhang, X., & Wu, Z. (2022). Pan-cancer analysis reveals homologous recombination deficiency score as a predictive marker for immunotherapy responders. Human cell, 35(1), 199-213. https://doi.org/10.1007/s13577-021-00630-z
Yang, Can, et al. "Pan-cancer analysis reveals homologous recombination deficiency score as a predictive marker for immunotherapy responders." Human cell vol. 35,1 (2022): 199-213. doi: https://doi.org/10.1007/s13577-021-00630-z
Yang C, Zhang Z, Tang X, Zhang X, Chen Y, Hu T, Zhang H, Guan M, Zhang X, Wu Z. Pan-cancer analysis reveals homologous recombination deficiency score as a predictive marker for immunotherapy responders. Hum Cell. 2022 Jan;35(1):199-213. doi: 10.1007/s13577-021-00630-z. Epub 2021 Oct 10. PMID: 34628623.
Copy
Download .nbib